Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Trillium Therapeutics Inc (TRIL.TO)

Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Trillium: Q3 Earnings Snapshot AP - Fri Nov 12, 2021

MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Friday reported a loss of $19.3 million in its third quarter.

TRIL.TO : 23.33 (+0.47%)
Trillium Therapeutics Receives Final Court Order Approving Arrangement Globe Newswire - Thu Oct 28, 2021

CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage...

TRIL : 18.44 (+2.62%)
TRIL.TO : 23.33 (+0.47%)
PFE : 26.27 (-0.19%)
Trillium Securityholders Approve Acquisition by Pfizer Globe Newswire - Tue Oct 26, 2021

CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage...

TRIL : 18.44 (+2.62%)
TRIL.TO : 23.33 (+0.47%)
PFE : 26.27 (-0.19%)
Two Trillion-Dollar Industries Being Transformed By Tech Baystreet - Thu Oct 21, 2021

Big money is pouring into two disruptive segments in two of the world’s biggest industries - ...

BEP : 21.66 (unch)
PLUG : 2.41 (-6.95%)
TRUE.CN : 0.7300 (+4.29%)
DXD : 33.10 (+0.33%)
TRIL.TO : 23.33 (+0.47%)
PBH.TO : 89.28 (+0.60%)
ONC.TO : 1.47 (+2.80%)
CRH.TO : 4.99 (+0.40%)
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector Baystreet - Mon Oct 18, 2021

A massive disruption now appears imminent in one of the world’s largest – and most important ...

TRUE.CN : 0.7300 (+4.29%)
TREIF : 0.5365 (+2.27%)
TRIL.TO : 23.33 (+0.47%)
ONC.TO : 1.47 (+2.80%)
HEXO.TO : 0.88 (+1.15%)
FTRP.CN : 5.550 (+1.46%)
Most actively traded companies on the Toronto Stock Exchange Canadian Press - Mon Aug 23, 2021

TORONTO — Some of the most active companies traded Monday on the Toronto Stock Exchange:

SU.TO : 53.79 (+0.60%)
ENB.TO : 48.86 (+0.93%)
MFC.TO : 32.15 (-0.19%)
HEXO.TO : 0.88 (+1.15%)
GWO.TO : 40.43 (+0.40%)
FTS.TO : 53.65 (+0.52%)
TRIL.TO : 23.33 (+0.47%)
RSI.TO : 5.19 (unch)
FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. THE CANADIAN PRESS/AP-Richard Drewm Fuke
Pfizer signs deal to buy Trillium Therapeutics for US$2.26 billion Canadian Press - Mon Aug 23, 2021

TORONTO — Trillium Therapeutics Inc. has signed a deal to be bought by Pfizer Inc. in an agreement valued at US$2.26 billion.

TRIL.TO : 23.33 (+0.47%)
Pfizer to Acquire Trillium Therapeutics Inc. Business Wire - Mon Aug 23, 2021

Pfizer Inc. (NYSE: PFE) and Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical...

TRIL : 18.44 (+2.62%)
TRIL.TO : 23.33 (+0.47%)
PFE : 26.27 (-0.19%)
Pfizer to Acquire Trillium Therapeutics Inc. Globe NewsWire - Mon Aug 23, 2021

Proposed acquisition strengthens Pfizer’s category leadership in Oncology with addition of next-generation, investigational immuno-therapeutics for hematological malignancies

TRIL : 18.44 (+2.62%)
TRIL.TO : 23.33 (+0.47%)
PFE : 26.27 (-0.19%)
Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results Globe NewsWire - Fri Aug 13, 2021

CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer,...

TRIL : 18.44 (+2.62%)
TRIL.TO : 23.33 (+0.47%)

Barchart Exclusives

3 Dividend Aristocrats to Buy on Every Dip Barchart - Wed Apr 24, 6:30PM CDT
As markets get wobbly, here are three Dividend Aristocrats to add a little stability to any portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot